- Investing Ideas
- /
- Hong Kong Undervalued Stocks Based On Cash Flows
Hong Kong Undervalued Stocks Based On Cash Flows
Results
27
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
27 companies
J&T Global Express
Market Cap: HK$61.3b
An investment holding company, offers integrated express delivery services in the People’s Republic of China, Indonesia, the Philippines, Malaysia, Thailand, Vietnam, Saudi Arabia, the United Arab Emirates, Mexico, Brazil, and Egypt.
1519
HK$6.88
7D
7.2%
1Y
-10.8%
Intron Technology Holdings
Market Cap: HK$1.5b
An investment holding company, operates as an automotive electronics solutions provider in Hong Kong, the Mainland China, and internationally.
1760
HK$1.42
7D
-3.4%
1Y
-22.0%
Zhejiang Leapmotor Technology
Market Cap: HK$75.9b
Engages in the research and development, production, and sale of new energy vehicles in Mainland China and internationally.
9863
HK$56.75
7D
-8.6%
1Y
101.6%
ASMPT
Market Cap: HK$22.4b
An investment holding company, engages in the design, manufacture, and marketing of machines, tools, and materials used in the semiconductor and electronics assembly industries worldwide.
522
HK$53.85
7D
1.0%
1Y
-45.4%
Lingbao Gold Group
Market Cap: HK$13.7b
Primarily engages in mining, processing, smelting, refining, and sale of gold products in the People’s Republic of China.
3330
HK$10.66
7D
6.2%
1Y
243.9%
Innovent Biologics
Market Cap: HK$102.4b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$62.10
7D
10.4%
1Y
76.2%
Bloks Group
Market Cap: HK$37.3b
Engages in the design, development, and sales of toy products in Mainland China.
325
HK$149.70
7D
-6.4%
1Y
n/a
RemeGen
Market Cap: HK$31.2b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.
9995
HK$46.35
7D
-6.3%
1Y
84.3%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$68.3b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$307.00
7D
-6.1%
1Y
89.4%
Maoyan Entertainment
Market Cap: HK$8.5b
An investment holding company, operates a platform in the entertainment industry in the People’s Republic of China.
1896
HK$7.36
7D
6.5%
1Y
-19.1%
Akeso
Market Cap: HK$78.0b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$86.95
7D
1.1%
1Y
171.7%
Genscript Biotech
Market Cap: HK$28.0b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$12.88
7D
9.5%
1Y
27.8%
WEILONG Delicious Global Holdings
Market Cap: HK$33.6b
Produces and sells spicy snack food in the People’s Republic of China and internationally.
9985
HK$13.82
7D
-11.3%
1Y
144.6%
Giant Biogene Holding
Market Cap: HK$72.0b
An investment holding company, designs, develops, and manufactures skin treatment products with recombinant collagen in the People’s Republic of China.
2367
HK$68.05
7D
-16.3%
1Y
37.9%
Bairong
Market Cap: HK$3.4b
Operates as a cloud-based AI turnkey services provider in China.
6608
HK$7.80
7D
-5.5%
1Y
-15.1%
Chow Tai Fook Jewellery Group
Market Cap: HK$114.9b
An investment holding company, manufactures and sells jewelry products in Mainland China, Hong Kong, Macau, and internationally.
1929
HK$11.50
7D
0.3%
1Y
13.9%
Jiangxi Rimag Group
Market Cap: HK$6.1b
Invests and operates medical imaging centers in China.
2522
HK$16.76
7D
-11.1%
1Y
n/a
MicroPort NeuroScientific
Market Cap: HK$6.0b
Engages in the research and development, production, and sale of neuro-interventional medical devices in the People’s Republic of China and internationally.
2172
HK$10.50
7D
4.2%
1Y
19.0%
CSC Financial
Market Cap: HK$174.7b
Provides investment banking services in Mainland China and internationally.
6066
HK$9.13
7D
1.4%
1Y
43.3%
Hangzhou SF Intra-city Industrial
Market Cap: HK$13.3b
An investment holding company, provides intra-city on-demand delivery services in the People’s Republic of China.
9699
HK$14.58
7D
32.5%
1Y
36.3%
Plover Bay Technologies
Market Cap: HK$6.6b
An investment holding company, designs, develops, and markets software defined wide area network routers.
1523
HK$6.02
7D
-1.0%
1Y
106.9%
Bosideng International Holdings
Market Cap: HK$51.5b
Engages in the apparel business in the People’s Republic of China.
3998
HK$4.50
7D
1.8%
1Y
-3.2%
Beijing Chunlizhengda Medical Instruments
Market Cap: HK$6.4b
Beijing Chunlizhengda Medical Instruments Co., Ltd.
1858
HK$11.10
7D
8.0%
1Y
14.7%
DPC Dash
Market Cap: HK$12.5b
Operates a chain of fast-food restaurants in the People’s Republic of China.
1405
HK$95.80
7D
-0.6%
1Y
78.1%
Nongfu Spring
Market Cap: HK$444.2b
Researches, develops, produces, and markets packaged drinking water and beverage products primarily in Mainland China.
9633
HK$39.50
7D
7.6%
1Y
-6.4%
Hua Hong Semiconductor
Market Cap: HK$64.9b
An investment holding company, engages in the manufacture and sale of semiconductor products in China, North America, Asia, Europe, and Japan.
1347
HK$32.55
7D
5.0%
1Y
61.5%
Chinasoft International
Market Cap: HK$12.8b
Engages in development and provision of information technology (IT) solutions, IT outsourcing, and training services in the People’s Republic of China, the United States, Malaysia, Japan, Singapore, India, and Saudi Arabia.
354
HK$5.16
7D
1.4%
1Y
25.9%